Pavicevic, S.; Reichelt, S.; Uluk, D.; Lurje, I.; Engelmann, C.; Modest, D.P.; Pelzer, U.; Krenzien, F.; Raschzok, N.; Benzing, C.;
et al. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers 2022, 14, 1026.
https://doi.org/10.3390/cancers14041026
AMA Style
Pavicevic S, Reichelt S, Uluk D, Lurje I, Engelmann C, Modest DP, Pelzer U, Krenzien F, Raschzok N, Benzing C,
et al. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers. 2022; 14(4):1026.
https://doi.org/10.3390/cancers14041026
Chicago/Turabian Style
Pavicevic, Sandra, Sophie Reichelt, Deniz Uluk, Isabella Lurje, Cornelius Engelmann, Dominik P. Modest, Uwe Pelzer, Felix Krenzien, Nathanael Raschzok, Christian Benzing,
and et al. 2022. "Prognostic and Predictive Molecular Markers in Cholangiocarcinoma" Cancers 14, no. 4: 1026.
https://doi.org/10.3390/cancers14041026
APA Style
Pavicevic, S., Reichelt, S., Uluk, D., Lurje, I., Engelmann, C., Modest, D. P., Pelzer, U., Krenzien, F., Raschzok, N., Benzing, C., Sauer, I. M., Stintzing, S., Tacke, F., Schöning, W., Schmelzle, M., Pratschke, J., & Lurje, G.
(2022). Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers, 14(4), 1026.
https://doi.org/10.3390/cancers14041026